GWM
TMO icon

GSB Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

GSB Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$463K Buy
942
+3
+0.3% +$1.63K 0.1% 146
2025
Q4 		$544K Sell
939
-4
-0.4% -$2.26K 0.12% 134
2025
Q3 		$458K Sell
943
-160
-15% -$74.5K 0.1% 144
2025
Q2 		$447K Buy
1,103
+107
+11% +$44.7K 0.11% 148
2025
Q1 		$496K Sell
996
-23
-2% -$12.5K 0.13% 137
2024
Q4 		$530K Sell
1,019
-18
-2% -$9.9K 0.14% 137
2024
Q3 		$642K Hold
1,037
– – 0.16% 126
2024
Q2 		$573K Hold
1,037
– – 0.16% 133
2024
Q1 		$603K Sell
1,037
-100
-9% -$56.1K 0.17% 130
2023
Q4 		$604K Hold
1,137
– – 0.19% 125
2023
Q3 		$576K Buy
1,137
+11
+1% +$5.86K 0.19% 121
2023
Q2 		$588K Hold
1,126
– – 0.19% 125
2023
Q1 		$649K Sell
1,126
-30
-3% -$16.9K 0.21% 127
2022
Q4 		$637K Sell
1,156
-1,005
-47% -$533K 0.23% 127
2022
Q3 		$1.1M Sell
2,161
-81
-4% -$45.3K 0.4% 92
2022
Q2 		$1.22M Hold
2,242
– – 0.42% 91
2022
Q1 		$1.32M Hold
2,242
– – 0.39% 91
2021
Q4 		$1.5M Buy
2,242
+472
+27% +$295K 0.43% 82
2021
Q3 		$1.01M Sell
1,770
-512
-22% -$281K 0.52% 59
2021
Q2 		$1.15M Buy
2,282
+170
+8% +$80.2K 0.36% 90
2021
Q1 		$964K Buy
+2,112
New +$1.01M 0.32% 98

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GSB Wealth Management's TMO Position: Q1 2026 in Review

GSB Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 0.32% in Q1 2026, buying an estimated $1.63K and bringing the position to 942 shares worth $463K. The position accounts for 0.1% of the portfolio, ranked #146.

GSB Wealth Management first reported a position in TMO in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.5M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • GSB Wealth Management held 942 shares of Thermo Fisher Scientific worth $463K as of Q1 2026.
  • GSB Wealth Management bought 3 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.63K.
  • Thermo Fisher Scientific made up 0.1% of GSB Wealth Management's portfolio in Q1 2026, its #146 holding.
  • GSB Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 21 quarters since.
  • GSB Wealth Management's Thermo Fisher Scientific position peaked at $1.5M in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on GSB Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.